Across the recent three months, 5 analysts have shared their insights on Century Therapeutics (NASDAQ:IPSC), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
1
0
0
0
Last 30D
1
0
0
0
0
1M Ago
1
0
0
0
0
2M Ago
0
1
0
0
0
3M Ago
2
0
0
0
0
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.6, a high estimate of $24.00, and a low estimate of $9.00. A decline of 2.86% from the prior average price target is evident in the current average.
Investigating Analyst Ratings: An Elaborate Study
An in-depth analysis of recent analyst actions unveils how financial experts perceive Century Therapeutics. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Mitchell Kapoor
HC Wainwright & Co.
Maintains
Buy
$11.00
$11.00
Mitchell Kapoor
HC Wainwright & Co.
Lowers
Buy
$11.00
$13.00
Edward Tenthoff
Piper Sandler
Lowers
Overweight
$9.00
$10.00
Bill Maughan
Canaccord Genuity
Raises
Buy
$24.00
$22.00
Mitchell Kapoor
HC Wainwright & Co.
Maintains
Buy
$13.00
-
Key Insights:
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related ...Full story available on Benzinga.com
Benzinga
